HRL Holdings Limited (ASX: HRL) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


HRL Holdings Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

  • HRL Holdings Limited (ASX: HRL)
    Latest News

    Two people shaking hands in the boardroom on a merger.
    Mergers & Acquisitions

    HRL share price jumps 10% as board backs takeover from ALS

    HRL has accepted ALS' takeover offer...

    Read more »

    A little girl with red hair runs excitedly with a rocket strapped to her back, trying to launch.
    Mergers & Acquisitions

    Guess which small-cap company is soaring 71% on a takeover bid from an ASX 200 share

    ALS’ non-binding takeover offer represents a massive premium on HRL’s recent share price.

    Read more »

    A man stands with arms crossed in front of a giant shadow of a body builder representing ASX small-cap stocks.
    Small Cap Shares

    Why this small-cap ASX share can follow $6 billion rival

    Nothing's a sure thing but one expert reckons he's found something special.

    Read more »


    HRL Holdings share price flies 20% on consensus-beating earnings guidance

    The HRL Holdings Ltd (ASX: HRL) share price is surging today on the back of a guidance and trading update.

    Read more »

    HRL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Gregory Francis Kilmister Non-Executive ChairmanNon-Executive Director Feb 2019
    Mr Kilmister was the Managing Director and Chief Executive Officer of ALS Limited, a global provider of laboratory testing, inspection, certification and verification solutions from 2005 until his retirement in July 2017. He is recognised as the pivotal force in the growth and transformation of ALS (formerly Campbell Brothers Limited) from a diversified industrial group to a globally respected Testing, Inspection & Certification (TIC) player and an ASX100 company. During his tenure ALS's market cap grew from $381 million in 2005 to over $3 billion in 2017 and the staff numbers increased from approximately 4,000 to over 13,000 worldwide when he retired. He has vast experience in operating laboratory focused businesses in the Environmental, Food, Pharmaceutical, Life Sciences, Minerals, Energy and Industrial sectors in more than seventy countries in Africa, Europe, Asia, Australia, and North and South America. Mr Kilmister was a Director of ALS Limited until retirement in July 2017. He is member of Risk Committee and People and Culture Committee.
    Mr James Scott Charles Todd Non-Executive Director Mar 2018
    Mr Todd is an experienced company director, corporate adviser and investor. He commenced his career in investment banking, and has taken active roles with, and invested in, a range of public and private companies. He was until recently Managing Director of Wolseley Private Equity, an independent private equity firm he co-founded in 1999. He is member of Risk Committee and chair of James Todd.
    Mr Steve Howse Executive Director Mar 2018
    Mr Howse was a former shareholder and director of Analytica Laboratories Limited. He continues his role with Analytica as Key Accounts & Projects Manager with a particular responsibility for strategy, clients, and business development. Mr Howse has over 25 years executive experience working in New Zealand science and technology businesses, with a focus on agribusiness and commercial analytical testing. He was a director of Synlait Farms Ltd leading up to its sale in 2014, and was deputy chair from 2014 to 2018 of Waikato Institute of Technology in New Zealand.
    Mr Alexander (Alex) James White Non-Executive Director Mar 2021
    Mr White is a Director of Richmond Hill Capital (RH Capital) and is jointly responsible for managing the RH High Conviction Fund. RH Capital has been invested in HRL for six years and is HRL's largest shareholder. Mr White has over fourteen years of corporate and investment management experience and prior to co-founding RH Capital, he was jointly responsible for the portfolio management of the VF High Conviction Fund at Viburnum Funds for six years (now the RH High Conviction Fund). Mr White joined Viburnum following over three years with Cooper Investors, a privately owned specialist investment manager, where he focused on investment research for the successful CI Australian Equities Fund and CI Brunswick Fund. He previously gained industry experience working for Fletcher Building as a Strategy Analyst and as a Credit Analyst for ratings agency Standard and Poor's. He is member of People and Culture Committee.
    Mr Richard Stephens Non-Executive Director Sep 2020
    Mr Stephens have senior executive experience at ASX-listed companies in the Testing, Inspection & Certification (TIC) and Banking & Finance sectors. From 2010 to 2018 he was Chief Financial Officer of ALS Limited - the global provider of laboratory focused TIC services. Richard has a deep knowledge of the value drivers in the industry and was heavily involved in acquisition and funding activities at ALS during that time. Previously he held senior finance roles with Suncorp and Metway Bank. He has financial governance experience with businesses spanning multiple jurisdictions, with expertise in the areas of capital management, debt and equity capital raisings, mergers and acquisitions, risk management and financial instruments.
    Mr Edmon Odza Alternate Director Nov 2021
    Mr Paul Marshall Company Secretary
    Mr Steven Dabelstein Chief Executive Officer Jan 2015
    Steven Dabelstein Chief Executive Officer
    Michael Harvey Chief Finance Officer
    Paul Marshall Company Secretary

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    J P Morgan Nominees Australia Pty Limited 170,359,917 34.50%
    National Nominees Limited 85,185,032 17.25%
    HGT Investments Pty Ltd 22,276,868 4.51%
    UBS Nominees Pty Ltd 21,573,000 4.37%
    HSBC Custody Nominees (Australia) Limited 19,689,967 3.99%
    Terrence Patrick Cooney & Julie Anne Cooney & Hugh Owen Cooney 16,670,891 3.38%
    Citicorp Nominees Pty Limited 11,489,524 2.33%
    Dixson Trust Pty Limited 7,312,879 1.48%
    Carolyn Joy Braggins & Terence John Braggins & Vosper Trustees 7,190,297 1.46%
    JNLJ Company Ltd 7,190,297 1.46%
    H K Price Pty Ltd 3,330,624 0.67%
    Custodial Services Limited 3,268,570 0.66%
    Mataranka Pty Ltd 3,036,486 0.61%
    Elliott Nominees Pty Ltd 3,033,119 0.61%
    Mr Jonathan Paul Kershaw Marshall 2,622,865 0.53%
    Mr Craig Anthony Anderson & Mrs Amanda Marie Anderson 2,445,528 0.50%
    Mr Gregory John Anderson & Mrs Nancy Joy Anderson 2,326,667 0.47%
    Estanza Pty Ltd 2,308,000 0.47%
    BNP Paribas Noms Pty Ltd 2,131,334 0.43%
    Denbass Pty Ltd 2,000,000 0.41%